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Background: Acute exacerbation of asthma is divided qualitatively into mild, moderate, and severe at-
tacks and respiratory failure. This system is, however, not suitable for estimating small changes in res-
piratory condition with time and for determining the efﬁcacy of treatments, because it has a qualitative,
but not quantitative nature.
Methods: To evaluate the usefulness of quantitative estimation of asthma exacerbation, modiﬁed Pul-
monary Index Score (mPIS) values were measured in 87 asthmatic children (mean age, 5.0 ± 0.4 years)
during hospitalization. mPIS was calculated by adding the sum of scores for 6 items (scores of 0e3 were
given for each item). These consisted of heart rate, respiratory rate, accessory muscle use, inspiratory-to-
expiratory ﬂow ratio, degree of wheezing, and oxygen saturation in room air. Measurements were made
at visits and at hospitalization and were then made twice a day until discharge.
Results: mPIS values were highly correlated among raters. mPIS values at visits were 9.1 ± 0.1 and
12.6 ± 0.4 in subjects with moderate and severe attacks, respectively (p < 0.001). mPIS values of subjects
requiring continuous inhalation therapy (CIT) with isoproterenol in addition to systemic steroids were
signiﬁcantly higher than the values of those without CIT (12.0 ± 0.5 and 9.3 ± 0.2, respectively, p < 0.001).
A score of 10 was suggested to be the optimal cutoff for distinguishing between subjects requiring and
not requiring CIT, from the perspectives of both sensitivity and speciﬁcity. mPIS at hospitalization
correlated well with the period until discharge, suggesting that this score was a useful predictor for the
clinical course after hospitalization.
Conclusions: mPIS could be a useful tool for several aspects during acute asthma attacks, including the
determination of a treatment plan, and prediction of the period of hospitalization in admitted patients,
although prospective studies would be required to establish our hypothesis.
Copyright © 2014, Japanese Society of Allergology. Production and hosting by Elsevier B.V. All rights reserved.Introduction
In Japan, the degree of severity of acute attacks of childhood
asthma is usually evaluated based on the Japanese Pediatric
Guideline for the Treatment and Management of Asthma 2012
(JPGL 2012).1 Severity is divided qualitatively into mild, moderate,, Saitama Medical University
n, Saitama 350-0495, Japan.
yama).
ety of Allergology.
rgology. Production and hosting by Elsand severe attacks and respiratory failure depending on the res-
piratory status, the patient's quality of life, and other aspects. This
system is, however, sometimes difﬁcult to use because of the
complexity of the evaluation items and thus yields discrepancies
between evaluators. In addition, it is not suitable for estimating
small changes in respiratory condition with time and for deter-
mining the efﬁcacy of treatments, because it has a qualitative, but
not quantitative nature.
Modiﬁed Pulmonary Index Score (mPIS) is a quantitative
method of evaluating respiratory conditions in asthmatic subjects
that was proposed by Carroll et al., in 2005.2 This method consists
of 6 evaluation items, which are important for the assessment ofevier B.V. All rights reserved.
Table 1
Proﬁles of study subjects (N ¼ 87).
Study period July 1, 2010eDecember
31, 2012
Age (mean±1SD) 0e15 (5.0±3.2) yrs
Sex
Male 57 (66%)
Female 30 (34%)
Classiﬁcation of asthma severity by JPGL 2012
Intermittent 45 (52%)
Mild persistent 16 (18%)
Moderate persistent 11 (12%)
Severe persistent 4 (4%)
First attack 11 (14%)
Severity of asthma exacerbation on visits
Mild 0 (0%)
Moderate 59 (67%)
Severe 28 (33%)
Respiratory failure 0 (0%)
Treatment after hospitalization
Systemic hydrocortisone without CIT 58 (67%)
Systemic hydrocortisone with CIT 29 (33%)
CIT, continuous inhalation therapy with isoproterenol.
T. Koga et al. / Allergology International 64 (2015) 139e144140dyspnea and are relatively easy to assess in clinical practice, namely
heart rate, respiratory rate, accessory muscle use, inspiratory-to-
expiratory ﬂow ratio, degree of wheezing, and oxygen saturation
in room air.
JPGL 2012 recommend that hospitalization should be consid-
ered in patients with acute attacks with moderate or higher
severity requiring systemic steroids. Continuous inhalation therapy
(CIT) with isoproterenol is recommended for hospitalized patients
with persistent dyspnea, in addition to systemic steroids.1,3e5
In the present study, we investigated the clinical usefulness of
evaluating mPIS for severe exacerbation in asthmatic children
requiring hospitalization. Thus, we measured the mPIS of hospi-
talized children after a hospital visit for acute exacerbation. For this
purpose, we examined the validity of this method among different
raters. In particular, we also evaluated clinical usefulness as a
treatment plan indicator and a clinical course predictor after
hospitalization.
Methods
Study subjects
Subjects of the present study were 87 asthmatic children (57
males and 30 females) who visited Saitama Medical University
Hospital for acute exacerbation during the period from July 2010 to
December 2012.
All subjects were hospitalized despite treatment in an emer-
gency room. The mean age was 5.0 years old (ranging from 0 to 15
years). Actual severity (severity considering current therapies
administered)1 in these subjects had been intermittent (n ¼ 45),
mild persistent (n ¼ 16), moderate persistent (n ¼ 11) and severe
persistent (n ¼ 4). In 11 patients, this was the ﬁrst episode of
asthma attack. The asthma attack severity was estimated by the
treated physician as moderate and severe according to the criteria
of JPGL 2012 in 59 (67%) and 28 (33%) subjects, respectively. Phy-
sicians in the emergency room treated each patient according to
JPGL 2012 for acute attacks. Patients without obvious improvement
in asthmatic symptoms despite treatment with inhaled beta 2 ag-
onists and some patients without obvious improvement in asth-
matic symptoms despite treatment with systemic steroids were
hospitalized. After hospitalization, all hospitalized patients
received systemic steroids. In addition, in some hospitalized pa-
tients requiring further treatments in addition to repeated inhala-
tion of beta 2 agonists because of persistence or worsening of
dyspnea, CIT with isoproterenol was initiated (CIT group, n ¼ 29,
33%) according to the criteria of JPGL 2012. The decision of initiation
was made based on the judgment of each physician in charge.
Patients without CIT (non-CIT group, n ¼ 58) inhaled short-
acting beta 2 agonists 4 times a day, in addition to systemic ste-
roids. Patients with obvious inﬁltration on chest radiography or
those complicated with other thoracic or cardiovascular diseases
such as tracheomalacia or congenital heart diseases were excluded
from the present study (Table 1).
This study was approved by the Ethics Committee of Saitama
Medical University (approval number, 13-075-1).
Measurement of mPIS
Measurement of mPIS was performed according to a previous
report.2 In brief, mPIS was calculated by adding the sum of scores
for 6 items (scores of 0e3 were given for each item). Thus, mPIS
ranged from 0 to 18, with the latter score being the most severe
condition. These 6 items consisted of heart rate, respiratory rate,
accessory muscle use, inspiratory-to-expiratory ﬂow ratio, degree
of wheezing, and oxygen saturation in room air (Table 2).Scores were determined for measurements in room air and,
when oxygen was used, they were measured after discontinuation
of oxygen for more than 2 min. In the case that SpO2 decreased
below 90% after discontinuation of oxygen, the scorewas deﬁned as
3 without waiting more than 2 min, and oxygenation was
reinitiated.
Measurements of mPIS were performed by a pediatrician at
Saitama Medical University Hospital (n ¼ 15) or a nurse in the pe-
diatric ward of SaitamaMedical University Hospital (n¼ 33). Before
measuring mPIS, all relevant staff had been trained on how to
evaluate mPIS; training involved watching a DVD prepared by the
study titled, “A comparison of continuous inhalation of salbutamol
and continuous inhalation of isoproterenol for severe pediatric
bronchial asthma: A multicenter, double-blind, randomized study”
(grant support from the Ministry of Health, Labour and Welfare).6
The mPIS of study subjects was principally measured at rest.
Measurements of mPIS at visits and at the time of hospitaliza-
tion (mPIS at hospitalization) were calculated by the physicianwho
examined each patient in the emergency room and by nurses in the
pediatric ward twice a day after hospitalization until discharge.
mPIS on discharge was deﬁned as mPIS on the day of discharge.
Relationships of mPIS among raters
To examine the relationships of mPIS among raters, 4 medical
staff (2 physicians and 2 nurses) measured the mPIS of the same
randomly selected patients at the same time during hospitalization.
These patients included 7 boys and 4 girls with themean ages of
6.0 ± 1.2 years old (2e13 years old).
The details of the raters were as follows: Physicians 1 and 2were
working as pediatricians for 6 years and 2 years, respectively, with
experience of measuring mPIS over 1 year and less than 1 year,
respectively. Nurses 1 and 2 were working for 6 years and 2 years,
respectively, with experience of measuringmPIS for over 1 year and
less than 1 year, respectively. These 4 raters went into the bedroom
of each selected patient and began measuring mPIS at the same
time. In all selected patients, the time was within 5 min in all raters
measuring mPIS.
mPIS and qualitative evaluation of asthma attack severity
At each visit, the physician who examined the study subject in
the emergency room measured mPIS in addition to qualitatively
Table 2
The modiﬁed Pulmonary Index Score.
Heart rate/min Respiratory rate/min Accessory
muscle use
Inhalation-exhalation
ratio
Wheezing Oxygen saturation
% (room air)
<3 years old S3 years old <6 years old S6 years old
0 <120 <100 &30 &20 None 2:1 None 96&
1 120e140 100e120 31e45 21e35 Mild 1:1 End expiratory 93e95
2 141e160 121e140 46e60 36e50 Moderate 1:2 Inspiratory and expiratory
wheeze, good aeration
90e92
3 160< 140< 60< 50< Severe 1:3 Inspiratory and expiratory
wheeze, decreased aeration
<90
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respiratory failure according to JPGL 2012. The relationships be-
tween these items were then analyzed.
mPIS at hospitalization and the duration of hospitalization
The correlation of mPIS at hospitalization with the duration of
hospitalization was evaluated in all study subjects.
Comparison between subjects with and without CIT with
isoproterenol
mPIS at hospitalization between subjects with and without CIT
with isoproterenol was compared. A receiver operating character-
istic curve (ROC curve) for these 2 groups was made to ﬁnd the
cutoff value for the indication of CIT. The relationship between
mPIS at hospitalization and the period of hospitalization was
examined among subjects with CIT.
Statistical analysis
A ManneWhitney U test was used for the comparison between
groups, and Spearman's rank correlation was used for the analysis
of correlations between groups. Data are presented as
means ± SEM. P values of <0.05 were considered to be signiﬁcant.
Results
Relationship of mPIS among raters
The degree of relatedness between raters in terms of mPIS is
shown in Fig. 1. The correlation was high irrespective of rater's
working experience, with correlation coefﬁcients (rs) ranging from
0.92 to 0.96 (p < 0.01 for all examinations).
Correlation of mPIS with qualitative evaluation of asthma attack
severity
mPIS values at visits in patients with moderate and severe at-
tacks were 9.1 ± 0.1 (5e12) and 12.6 ± 0.4 (9e17), respectively.
There was a signiﬁcant difference between groups (p < 0.001).
However, it was found that several patients with severe attacks
showed lower mPIS values compared with the values of those with
moderate attacks (Fig. 2).
Changes in mPIS after visiting the emergency room
The mean mPIS values of all study subjects after visiting the
emergency roomwere 10.2 ± 0.3, 9.0 ± 0.3, and 1.9 ± 0.2 at the time
of visits, at hospitalization, and on discharge, respectively (Fig. 3).
The mean duration of hospitalization was 5.4 ± 0.2 days (2e13
days), and a signiﬁcant correlation was found between mPIS at
hospitalization and the duration of hospitalization (rs ¼ 0.34,
p < 0.01, Fig. 4)Comparison between subjects with and without CIT with
isoproterenol
mPIS values at hospitalization were 12.0 ± 0.5 and 9.3 ± 0.2 in
subjects with and without CIT, respectively. A signiﬁcantly higher
value was observed in subjects with CIT than in those without CIT
(p < 0.001). However, it was found that several patients with CIT
showed lower mPIS values compared with the values shown by
those without CIT (Fig. 5).
An ROC curve for the indication of CIT according to mPIS
values of subjects with and without CIT is shown in Fig. 6. A value
of 10 was demonstrated to be the optimal cutoff for dis-
tinguishing between patients requiring CIT and those not
requiring it, from the perspectives of both sensitivity (72%) and
speciﬁcity (78%).
The mean hospitalization period in subjects with CIT was
6.3 ± 0.4 days (3e13 days), and mPIS values at hospitalization and
hospitalization period correlated well in these subjects (rs ¼ 0.53,
p < 0.01) (Fig. 4).
Discussion
In the present study, we showed that mPIS value was highly
correlated among raters. This method could be a useful tool for
several aspects during acute asthma attacks, including the deter-
mination of a treatment plan, and prediction of the period of hos-
pitalization in admitted patients, although our study design was
retrospective but not prospective.
In JPGL 2012, asthma attack severity is qualitatively estimated as
mild, moderate, and severe attacks and respiratory failure based on
conditions such as respiration status, feeling of dyspnea, quality of
life, and the degree of unconsciousness, part of which are subjective
rather than objective. In addition, this method is not suitable for the
evaluation of changes in symptoms or for evaluating treatment
effects because of its qualitative nature. For these reasons, we
wanted to examine the usefulness of the quantitative evaluation of
asthma attack severity by employing mPIS. Thus, we measured
changes in mPIS with time after visiting an ER and then after
hospitalization.
Carroll et al.2 modiﬁed the pulmonary index reported by Becker
et al.7 as mPIS by adding 2 scoring items, namely heart rate and
SpO2 at room temperature, and by dividing the method of heart
rate and respiratory rate scoring depending on which of 2 age
groups the patient belong to. They compared mPIS measured by
physicians, nurses, and respiratory therapists in 30 hospitalized
patients with asthma attacks. As a result, they found high correla-
tions of mPIS among these 3 professions. Several scoring systems
have been previously proposed.810 Among them, we have adopted
mPIS in the present study because of the reasons below. First, as
mentioned above, mPIS has been shown to be highly correlated
among raters. Secondly, we could train ourselves using an educa-
tional DVD6 to learn howwe could perform evaluations for mPIS. In
the present study, similar to Carroll et al.,2 we also wanted to
examine the correlation of mPIS among raters. As a result,
Fig. 1. Relationship of mPIS among 4 different observers. mPIS of 11 study subjects was measured by 4 observers (Physicians 1 and 2 and Nurses 1 and 2) at the same time points.
Physician 1 and Nurse 1 had over 1 year of experience in measuring mPIS, while Physician 2 and Nurse 2 had less than 1 year of experience.
T. Koga et al. / Allergology International 64 (2015) 139e144142correlations among 4 raters, of whom 2were physicians and 2 were
nurses, were very high irrespective of their professions or their
working experience, supporting the results of the report by Carroll
et al.2 Buyuktiryaki et al.11 showed thatmPISmight be useful for the
determination of admission for asthma attacks by making ROC
curves, although they did not evaluate the correlation among
raters. Our present study showed the possibility that mPISmight be
also useful for the determination of a treatment plan, including the
indication of CIT, and prediction of the period of hospitalization in
admitted patients.
In the present study, mPIS of subjects with severe attacks was
signiﬁcantly higher than that of those with moderate severity.
However, several patients were judged as having severe attacks,
even though their mPIS values were relatively low. On the contrary,some were judged as having moderate attacks despite high mPIS
values. A possible reason for the divergence between mPIS and the
estimate of asthma attack severity is that the latter was likely to be
affected by the strength of apparent symptoms. Namely, there was
a tendency that the severity was estimated to be severe when a
symptom that might suggest dyspnea was apparent. For example,
there were 17 patients with an mPIS of 12 in the present study.
Among these, 7 and 10 subjects were judged as having moderate
and severe attacks, respectively. When noticing the degree of
wheezing in mPIS, an item that might strongly suggest dyspnea,
none of the 7 patients with moderate attack were given scores of 3,
the maximum for this item, while this was the case for 8 of 10
patients with severe attacks. On the other hand, 5 patients were
judged as having severe attacks despite low mPIS values (10). In
Fig. 4. Relationship between mPIS at hospitalization and the period until discharge.
Open and closed circles indicate subjects with and without CIT, respectively. In all
study subjects, a signiﬁcant relationship was found (r ¼ 0.34, p < 0.01). This was also
the case when the relationship was examined in only subjects with CIT (r ¼ 0.53,
p < 0.01).
Fig. 5. Comparison of mPIS at hospitalization between subjects with and without CIT.
mPIS was signiﬁcantly higher in subjects with CIT (12.0 ± 0.5) than in those without
CIT (9.3 ± 0.2). *p < 0.001. CIT, Continuous inhalation therapy with isoproterenol.
Fig. 2. Comparison of mPIS at visits between subjects with moderate and severe se-
verities, estimated by a qualitative method. Both parameters were measured at the
same time by the same physicians. mPIS was signiﬁcantly higher in severe subjects
(12.6 ± 0.6) than in moderate subjects (9.1 ± 0.1). *p < 0.001.
T. Koga et al. / Allergology International 64 (2015) 139e144 143these subjects, it was possible that the severity had been over-
estimated because of complications such as severe rhinitis or
bronchitis.
An analysis of the ROC curve found that an mPIS value of 10 was
the optimal cutoff for the indication of CIT, from perspectives of
both sensitivity and speciﬁcity. According to the criteria of JPGL
2012, we performed CIT in selected patients requiring further
treatments in addition to repeated inhalation of beta 2 agonists
because of persistence or worsening of dyspnea. The decision was
made by each physician in charge. However, some patients in the
present study with mPIS values of 10 or more were found to have
not undergone CIT. On the contrary, some subjects underwent CIT
even though their mPIS values were less than 9. A possible reason
for this discrepancy is that CIT tended to be applied to cases in
which apparent symptoms were more severe. For example, we
have examined study subjects with mPIS values of 9e11, a range in
which there were both cases with and without CIT. As a result, CIT
was applied to 18 cases (69%) among 26 subjects whose mPIS was
scored as 3, the most severe score, for at least 1 item. In contrast,
only 5 cases (33%) among 15 patients who were scored from 1 to 2
for all mPIS items underwent CIT. A prospective study might be
required for better understanding of the optimal cutoff point.
Nevertheless, this study suggested that adopting quantitative
methods such as mPIS, in addition to the conventional qualitativeFig. 6. ROC curve analysis for determining the indication of CIT using mPIS at hospi-
talization. A score of 10 was the optimal cutoff from perspectives of both sensitivity
and speciﬁcity (74% and 78%, respectively).
Fig. 3. Mean mPIS values of all study subjects at each time point during hospitaliza-
tion. The mean mPIS values at visits, at hospitalization, and on discharge were
10.2 ± 0.3, 9.0 ± 0.3, and 1.9 ± 0.2, respectively.
T. Koga et al. / Allergology International 64 (2015) 139e144144ones, might help in determining whether to use CIT for acute
exacerbation of asthma.
In the present study, there was a signiﬁcant correlation between
mPIS at hospitalization and hospitalization period, suggesting that
mPIS was useful for predicting the clinical course after hospitali-
zation. However, the correlation coefﬁcient was not so high.
Regarding the reason, it was possible that some patients whose
symptoms exacerbated after hospitalization showed a lowered
coefﬁcient. It was also likely that hospitalization period had been
partly affected by several reasons such as the convenience of the
patient's guardians. The results of the present study were obtained
via a retrospective method. Thus, a prospective protocol would
further clarify the usefulness of mPIS as a predictor for hospitali-
zation period.
Acknowledgments
Part of this work was presented as a poster presentation at the
European Respiratory Society Meeting 2013 (Barcelona, Spain).
The authors would like to thank pediatricians of Saitama Med-
ical University and nurses working in the pediatric ward of Saitama
Medical University Hospital for their scoring of mPIS in admitted
patients.
Conﬂict of interest
The authors have no conﬂict of interest to declareReferences
1. Hamasaki Y, Kohno Y, Ebisawa M, Kondo N. Japanese Society of Pediatric Al-
lergy and Clinical Immunology. [Japanese Pediatric Guideline for the Treatment
and Management of Asthma 2012]. Tokyo: Kyowa Kikaku; 2012 (in Japanese).
2. Carroll CL, Sekaran AK, Lerer TJ, Schramm CM. A modiﬁed pulmonary index
score with predictive value for pediatric asthma exacerbations. Ann Allergy
Asthma Immunol 2005;94:355e9.
3. Inui H, Obata T, Uekusa T, Kishida M, Watanabe K, Iikura Y, et al. [Isoproterenol
therapy for childhood status asthmaticus]. [Jpn J Pediatr Allergy Clin Immunol]
1988;2:28e35 (in Japanese).
4. Takamasu T, Kurihara K, Goto K. [Isoproterenol continuous nebulization of
childhood status asthmaticus: II. Efﬁcacy and side effects of low-dose method
comparing with high-dose method]. [Jpn J Pediatr Allergy Clin Immunol]
1998;47:573e81 (in Japanese).
5. Sekine K, Aoyagi M, Nishimuta T. Continuous isoproterenol inhalation therapy
for severe asthma attacks in children. Asthma 1998;11:67e72.
6. Katsunuma T. [A Comparison of Continuous Inhalation of Salbutamol and
Continuous Inhalation of Isoproterenol for Severe Pediatric Bronchial Asthma: a
Multicenter, Double-blind, Randomized Study]. Report for grant support from the
Ministry of Health, Labour and Welfare of Japan; 2010 (in Japanese).
7. Becker AB, Nelson NA, Simons FE. The pulmonary index. Assessment of a
clinical score for asthma. Am J Dis Child 1984;138:574e6.
8. Ducharme FM, Chalut D, Plotnick L, Savdie C, Kudirka D, Zhang X, et al. The
Pediatric Respiratory Assessment Measure: a valid clinical score for assessing
acute asthma severity from toddlers to teenagers. J Pediatr 2008;152:476e80.
9. Greenberg S, Liu N, Kaur A, Lakshminarayanan M, Zhou Y, Nelsen L, et al. The
asthma disease activity score: a discriminating, responsive measure predicts
future asthma attacks. J Allergy Clin Immunol 2012;130:1071e7.
10. Birken CS, Parkin PC, Macarthur C. Asthma severity scores for preschoolers
displayed weaknesses in reliability, validity, and responsiveness. J Clin Epi-
demiol 2004;57:1177e81.
11. Buyuktiryaki AB, Civelek E, Can D, Orhan F, Aydogan M, Reisli I, et al. Predicting
hospitalization in children with acute asthma. J Emerg Med 2013;44:919e27.
